IBDEI0BO ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5513,1,3,0)
 ;;=3^249.80
 ;;^UTILITY(U,$J,358.3,5513,1,4,0)
 ;;=4^SEC DM OTH DISORDER NOT UNCNTRLD
 ;;^UTILITY(U,$J,358.3,5513,2)
 ;;=^336736
 ;;^UTILITY(U,$J,358.3,5514,0)
 ;;=249.81^^43^489^14
 ;;^UTILITY(U,$J,358.3,5514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5514,1,3,0)
 ;;=3^249.81
 ;;^UTILITY(U,$J,358.3,5514,1,4,0)
 ;;=4^SEC DM OTHER UNCONTRLD
 ;;^UTILITY(U,$J,358.3,5514,2)
 ;;=^336535
 ;;^UTILITY(U,$J,358.3,5515,0)
 ;;=250.50^^43^490^3
 ;;^UTILITY(U,$J,358.3,5515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5515,1,3,0)
 ;;=3^250.50
 ;;^UTILITY(U,$J,358.3,5515,1,4,0)
 ;;=4^DMII OPHTH CONTROLLED
 ;;^UTILITY(U,$J,358.3,5515,2)
 ;;=^331799
 ;;^UTILITY(U,$J,358.3,5516,0)
 ;;=250.51^^43^490^1
 ;;^UTILITY(U,$J,358.3,5516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5516,1,3,0)
 ;;=3^250.51
 ;;^UTILITY(U,$J,358.3,5516,1,4,0)
 ;;=4^DMI OPHTH CONTROLLED
 ;;^UTILITY(U,$J,358.3,5516,2)
 ;;=^331800
 ;;^UTILITY(U,$J,358.3,5517,0)
 ;;=250.52^^43^490^4
 ;;^UTILITY(U,$J,358.3,5517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5517,1,3,0)
 ;;=3^250.52
 ;;^UTILITY(U,$J,358.3,5517,1,4,0)
 ;;=4^DMII OPHTH UNCNTRLD
 ;;^UTILITY(U,$J,358.3,5517,2)
 ;;=^331801
 ;;^UTILITY(U,$J,358.3,5518,0)
 ;;=250.53^^43^490^2
 ;;^UTILITY(U,$J,358.3,5518,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5518,1,3,0)
 ;;=3^250.53
 ;;^UTILITY(U,$J,358.3,5518,1,4,0)
 ;;=4^DMI OPHTH UNCNTRLD
 ;;^UTILITY(U,$J,358.3,5518,2)
 ;;=^331802
 ;;^UTILITY(U,$J,358.3,5519,0)
 ;;=271.4^^43^491^9
 ;;^UTILITY(U,$J,358.3,5519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5519,1,3,0)
 ;;=3^271.4
 ;;^UTILITY(U,$J,358.3,5519,1,4,0)
 ;;=4^RENAL GLYCOSURIA
 ;;^UTILITY(U,$J,358.3,5519,2)
 ;;=^52318
 ;;^UTILITY(U,$J,358.3,5520,0)
 ;;=790.21^^43^491^2
 ;;^UTILITY(U,$J,358.3,5520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5520,1,3,0)
 ;;=3^790.21
 ;;^UTILITY(U,$J,358.3,5520,1,4,0)
 ;;=4^IMPAIRED FASTING GLUCOSE
 ;;^UTILITY(U,$J,358.3,5520,2)
 ;;=^329895
 ;;^UTILITY(U,$J,358.3,5521,0)
 ;;=790.22^^43^491^3
 ;;^UTILITY(U,$J,358.3,5521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5521,1,3,0)
 ;;=3^790.22
 ;;^UTILITY(U,$J,358.3,5521,1,4,0)
 ;;=4^IMPAIRED GLUCOSE TOLERANCE TEST
 ;;^UTILITY(U,$J,358.3,5521,2)
 ;;=^329896
 ;;^UTILITY(U,$J,358.3,5522,0)
 ;;=790.29^^43^491^6
 ;;^UTILITY(U,$J,358.3,5522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5522,1,3,0)
 ;;=3^790.29
 ;;^UTILITY(U,$J,358.3,5522,1,4,0)
 ;;=4^OTH ABNORMAL GLUCOSE
 ;;^UTILITY(U,$J,358.3,5522,2)
 ;;=^329955
 ;;^UTILITY(U,$J,358.3,5523,0)
 ;;=791.0^^43^491^8
 ;;^UTILITY(U,$J,358.3,5523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5523,1,3,0)
 ;;=3^791.0
 ;;^UTILITY(U,$J,358.3,5523,1,4,0)
 ;;=4^PROTEINURIA
 ;;^UTILITY(U,$J,358.3,5523,2)
 ;;=^99873
 ;;^UTILITY(U,$J,358.3,5524,0)
 ;;=277.1^^43^491^1
 ;;^UTILITY(U,$J,358.3,5524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5524,1,3,0)
 ;;=3^277.1
 ;;^UTILITY(U,$J,358.3,5524,1,4,0)
 ;;=4^DYSMETABOLIC SYNDROME X
 ;;^UTILITY(U,$J,358.3,5524,2)
 ;;=^35630
 ;;^UTILITY(U,$J,358.3,5525,0)
 ;;=278.00^^43^491^5
 ;;^UTILITY(U,$J,358.3,5525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5525,1,3,0)
 ;;=3^278.00
 ;;^UTILITY(U,$J,358.3,5525,1,4,0)
 ;;=4^OBESITY
 ;;^UTILITY(U,$J,358.3,5525,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,5526,0)
 ;;=278.01^^43^491^4
 ;;^UTILITY(U,$J,358.3,5526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5526,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,5526,1,4,0)
 ;;=4^MORBID OBESITY
 ;;^UTILITY(U,$J,358.3,5526,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,5527,0)
 ;;=278.02^^43^491^7
 ;;^UTILITY(U,$J,358.3,5527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5527,1,3,0)
 ;;=3^278.02
